Strategic Assets

Innoviva is a diversified biopharmaceutical company with three primary divisions

Strategic Assets

Royalty Portfolio

 

A durable royalty stream from two differentiated respiratory products marketed by GSK.

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Critical Care and Infectious Disease Therapeutics

 

Robust integrated biopharma platform anchored by 3 best in class marketed products and a promising late-stage pipeline.

Learn more at Innoviva Specialty Therapeutics

XACDURO Logo

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Strategic Healthcare Assets

 

A diversified portfolio of healthcare investments with high growth potential and demonstrated resilience.

Long-term strategic partner with commitment spanning years

Interest in and differentiated ability to help companies succeed

Critical Care and ID Therapeutics


Robust integrated biopharma platform anchored by 2 best in class marketed products and a promising late-stage pipeline.

Learn more at Innoviva Specialty Therapeutics

Innoviva Specialty Therapeutics

Giapreza

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.

Xerava

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industrys standard dummy text ever since the 1500s.